The emerging approach of the medication represents a exciting development in the management of the condition. Different to existing therapies, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide540539.webdesign96.com/42293102/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment